Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP704017.RAU2vGtpN6P24My40I0HAemdva-gd4RJ_5wNgklbqYumg130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP704017.RAU2vGtpN6P24My40I0HAemdva-gd4RJ_5wNgklbqYumg130_assertion type Assertion NP704017.RAU2vGtpN6P24My40I0HAemdva-gd4RJ_5wNgklbqYumg130_head.
- NP704017.RAU2vGtpN6P24My40I0HAemdva-gd4RJ_5wNgklbqYumg130_assertion description "[Relative to the most frequent GATA haplotype, the GATG haplotype was associated with statistically significant increased gastric cancer risk (OR = 1.50, 95% CI: 1.06-2.12; false discovery rate (FDR) value = 0.459) and the AACA haplotype with borderline increased risk (OR = 1.36, 95% CI = 1.00-1.85; FDR = 0.50).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP704017.RAU2vGtpN6P24My40I0HAemdva-gd4RJ_5wNgklbqYumg130_provenance.
- NP704017.RAU2vGtpN6P24My40I0HAemdva-gd4RJ_5wNgklbqYumg130_assertion evidence source_evidence_literature NP704017.RAU2vGtpN6P24My40I0HAemdva-gd4RJ_5wNgklbqYumg130_provenance.
- NP704017.RAU2vGtpN6P24My40I0HAemdva-gd4RJ_5wNgklbqYumg130_assertion SIO_000772 19015200 NP704017.RAU2vGtpN6P24My40I0HAemdva-gd4RJ_5wNgklbqYumg130_provenance.
- NP704017.RAU2vGtpN6P24My40I0HAemdva-gd4RJ_5wNgklbqYumg130_assertion wasDerivedFrom befree-2016 NP704017.RAU2vGtpN6P24My40I0HAemdva-gd4RJ_5wNgklbqYumg130_provenance.
- NP704017.RAU2vGtpN6P24My40I0HAemdva-gd4RJ_5wNgklbqYumg130_assertion wasGeneratedBy ECO_0000203 NP704017.RAU2vGtpN6P24My40I0HAemdva-gd4RJ_5wNgklbqYumg130_provenance.